August 2014

A new long-term treatment for the third largest killer of U.S. citizens - chronic obstructive pulmonary disease (COPD) – was approved today by the U.S. Food and Drug Administration. Striverdi Respimat (olodaterol), an inhalation spray, is for the treatment of patients with COPD, including chronic...